Literature DB >> 33664017

Ambulatory Function and Mortality among Cancer Survivors in the NIH-AARP Diet and Health Study.

Elizabeth A Salerno1,2,3, Pedro F Saint-Maurice3, Erik A Willis4, Steven C Moore3, Loretta DiPietro5, Charles E Matthews3.   

Abstract

BACKGROUND: There is limited evidence describing associations between cancer and function in diverse cancer types and its relationship with mortality. We investigated the relationship between cancer and poor ambulatory function and associations between ambulatory function and subsequent mortality.
METHODS: Participants included 233,135 adults (n = 30,403 cancer and n = 202,732 cancer free) in the NIH-American Association of Retired Persons Diet and Health Study (1994-1996) who self-reported ambulatory function (e.g., walking pace and mobility disability: being unable to walk or walking at the slowest pace) in 2004-2006. Participants were followed for mortality from the assessment of ambulatory function through 2011. Multinomial logistic regression quantified the association between cancer and ambulatory function. We then explored the independent effects of walking pace and mobility disability in cancer survivors, and the joint effects of both a cancer diagnosis and poor ambulatory function on mortality using Cox proportional hazards models. Models explored type-specific associations across 15 cancer types.
RESULTS: Survivors had 42% greater odds of walking at the slowest pace [OR, 1.42 (confidence interval (CI), 1.30-1.54)] and 24% greater odds of mobility disability [OR, 1.24 (CI, 1.17-1.31)], compared with cancer-free participants, adjusting for baseline demographics, health indicators, and cancer type. Survivors reporting the slowest pace were at increased hazards than those who walked the fastest: all-cause mortality [HR, 2.22 (CI, 2.06-2.39)] and cancer mortality [HR, 2.12 (CI, 1.83-2.45)]. Similar trends emerged for mobility disability (HRs > 1.64). All-cause mortality associations were significant for more than nine cancer types.
CONCLUSIONS: A diagnosis of cancer is associated with poorer ambulatory function, which is subsequently associated with increased mortality. IMPACT: Widespread efforts should target ambulatory function during cancer survivorship for survival benefits. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 33664017      PMCID: PMC8300589          DOI: 10.1158/1055-9965.EPI-20-1473

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  39 in total

1.  Physical and mental health status of older long-term cancer survivors.

Authors:  Nancy L Keating; Marie Nørredam; Mary Beth Landrum; Haiden A Huskamp; Ellen Meara
Journal:  J Am Geriatr Soc       Date:  2005-12       Impact factor: 5.562

2.  Self-rated walking pace and all-cause, cardiovascular disease and cancer mortality: individual participant pooled analysis of 50 225 walkers from 11 population British cohorts.

Authors:  Emmanuel Stamatakis; Paul Kelly; Tessa Strain; Elaine M Murtagh; Ding Ding; Marie H Murphy
Journal:  Br J Sports Med       Date:  2018-06       Impact factor: 13.800

3.  Cancer treatment and survivorship statistics, 2019.

Authors:  Kimberly D Miller; Leticia Nogueira; Angela B Mariotto; Julia H Rowland; K Robin Yabroff; Catherine M Alfano; Ahmedin Jemal; Joan L Kramer; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-06-11       Impact factor: 508.702

4.  Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

Authors:  A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

Review 5.  Promoting health and physical function among cancer survivors: potential for prevention and questions that remain.

Authors:  Wendy Demark-Wahnefried; Bernardine M Pinto; Ellen R Gritz
Journal:  J Clin Oncol       Date:  2006-11-10       Impact factor: 44.544

Review 6.  Cancer survivorship and aging.

Authors:  Nancy E Avis; Gary T Deimling
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

Review 7.  Cancer survivorship and aging : moving the science forward.

Authors:  Keith M Bellizzi; Karen M Mustian; Oxana G Palesh; Michael Diefenbach
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

8.  Functional impact of breast cancer by age at diagnosis.

Authors:  Candyce H Kroenke; Bernard Rosner; Wendy Y Chen; Ichiro Kawachi; Graham A Colditz; Michelle D Holmes
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

9.  Functioning and activity participation restrictions among older adult, long-term cancer survivors.

Authors:  Gary T Deimling; Samantha Sterns; Karen F Bowman; Boaz Kahana
Journal:  Cancer Invest       Date:  2007-03       Impact factor: 2.176

10.  Mobility Device Use and Mobility Disability in U.S. Medicare Beneficiaries With and Without Cancer History.

Authors:  Shirley M Bluethmann; Eileen Flores; Grace Campbell; Heidi D Klepin
Journal:  J Am Geriatr Soc       Date:  2020-09-24       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.